Literature DB >> 2872208

Pharmacotherapeutic considerations in anxiety disorders.

L E Hollister.   

Abstract

Anxiety disorders comprise a variety of syndromes that require varied pharmacotherapeutic, psychotherapeutic, and behavioral interventions. Benzodiazepines have now replaced older sedatives and hypnotics as the preferred drug treatment for generalized anxiety. For panic disorder and agoraphobia with panic, the tricyclic antidepressants, the monoamine oxidase inhibitors, and the atypical benzodiazepine alprazolam have proved effective. When a simple phobia is severe enough to require treatment, behavioral approaches, with the possible adjunctive use of benzodiazepines, are recommended. Careful diagnostic inquiry, individual titration of doses, and use of conservative dosage schedules (with interrupted periods of treatment) will permit pharmacotherapy with maximum benefit and a minimum of adverse consequences.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872208

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

Review 1.  New drugs. Hypnotics and anxiolytics.

Authors:  B R Ballinger
Journal:  BMJ       Date:  1990-02-17

2.  Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder.

Authors:  Michael J Zvolensky; Peter Lewinsohn; Amit Bernstein; Norman B Schmidt; Julia D Buckner; John Seeley; Marcel O Bonn-Miller
Journal:  J Psychiatr Res       Date:  2008-02-20       Impact factor: 4.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.